Clinical Trials Directory

Trials / Unknown

UnknownNCT03218579

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators would like to examine the extent of gut microbiome rehabilitation in healthy people after the consumption of antibiotics. Outcomes of probiotic treatment versus bacteriotherapy will be compared.

Detailed description

The investigators would like to examine the extent of rehabilitation of the composition and functioning of the intestinal bacteria in healthy people after the consumption of antibiotics. Since the digestive mocus enables the connection between the host and the bacteria that live within it, the investigators would like to characterize the microbiome in the different areas along the digestive system - before antibiotic treatment and after rehabilitation by probiotic treatment versus bacteriotherapy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic treatment4 weeks of probiotic treatment after 7 days of antibiotics (Metronidazole+Ciprofloxacin)
BIOLOGICALBacteriotherapyBacteriotherapy (autologous fecal microbiota transplantation) after 7 days of antibiotics (Metronidazole+Ciprofloxacin)

Timeline

Start date
2013-02-01
Primary completion
2019-12-30
Completion
2020-12-30
First posted
2017-07-14
Last updated
2017-07-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03218579. Inclusion in this directory is not an endorsement.

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions (NCT03218579) · Clinical Trials Directory